Insider Transactions in Q2 2025 at Nuvalent, Inc. (NUVL)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 27
2025
|
Alexandra Balcom Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
20,000
-24.47%
|
$1,600,000
$80.02 P/Share
|
|
Jun 27
2025
|
Alexandra Balcom Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+19.66%
|
$360,000
$18.93 P/Share
|
|
Jun 27
2025
|
Henry E. Pelish Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,170
-3.32%
|
$171,430
$79.92 P/Share
|
|
Jun 27
2025
|
Henry E. Pelish Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,170
+1.63%
|
$60,760
$28.59 P/Share
|
|
Jun 26
2025
|
Darlene Noci Chief Development Officer |
SELL
Open market or private sale
|
Direct |
4,000
-2.58%
|
$312,000
$78.41 P/Share
|
|
Jun 26
2025
|
Darlene Noci Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+7.14%
|
$108,000
$27.85 P/Share
|
|
Jun 25
2025
|
Henry E. Pelish Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
8,630
-12.03%
|
$681,770
$79.87 P/Share
|
|
Jun 25
2025
|
Henry E. Pelish Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,630
+5.84%
|
$241,640
$28.59 P/Share
|
|
Jun 18
2025
|
James E Flynn Director |
BUY
Grant, award, or other acquisition
|
Indirect |
5,294
+50.0%
|
-
|
|
Jun 18
2025
|
Cameron Wheeler |
BUY
Grant, award, or other acquisition
|
Direct |
2,647
+33.97%
|
-
|
|
Jun 18
2025
|
Michael L. Meyers |
BUY
Grant, award, or other acquisition
|
Direct |
2,647
+33.97%
|
-
|
|
Jun 18
2025
|
Joseph Pearlberg |
BUY
Grant, award, or other acquisition
|
Direct |
2,647
+33.97%
|
-
|
|
Jun 18
2025
|
Anna Protopapas |
BUY
Grant, award, or other acquisition
|
Direct |
2,647
+33.97%
|
-
|
|
Jun 18
2025
|
Matthew Shair |
BUY
Grant, award, or other acquisition
|
Direct |
2,647
+0.18%
|
-
|
|
Jun 18
2025
|
Sapna Srivastava |
BUY
Grant, award, or other acquisition
|
Direct |
2,647
+33.97%
|
-
|
|
Jun 18
2025
|
Christy J. Oliger |
BUY
Grant, award, or other acquisition
|
Direct |
3,971
+50.0%
|
-
|
|
Jun 18
2025
|
Grant C. Bogle |
BUY
Grant, award, or other acquisition
|
Direct |
2,647
+31.16%
|
-
|
|
Jun 16
2025
|
James Richard Porter President and CEO |
SELL
Open market or private sale
|
Direct |
27,000
-3.34%
|
$2,079,000
$77.38 P/Share
|
|
Jun 16
2025
|
James Richard Porter President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
27,000
+8.91%
|
$729,000
$27.85 P/Share
|
|
Jun 06
2025
|
Henry E. Pelish Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
200
-0.32%
|
$15,800
$79.82 P/Share
|
|
Jun 06
2025
|
Henry E. Pelish Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
200
+0.16%
|
$5,600
$28.59 P/Share
|
|
May 29
2025
|
Darlene Noci Chief Development Officer |
SELL
Open market or private sale
|
Direct |
4,000
-3.88%
|
$284,000
$71.46 P/Share
|
|
May 29
2025
|
Darlene Noci Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+3.77%
|
$84,000
$21.13 P/Share
|
|
May 15
2025
|
James Richard Porter President and CEO |
SELL
Open market or private sale
|
Direct |
27,000
-3.35%
|
$1,890,000
$70.01 P/Share
|
|
May 15
2025
|
James Richard Porter President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
27,000
+8.91%
|
$729,000
$27.85 P/Share
|
|
Apr 29
2025
|
Darlene Noci Chief Development Officer |
SELL
Open market or private sale
|
Direct |
4,000
-7.69%
|
$296,000
$74.56 P/Share
|
|
Apr 29
2025
|
Darlene Noci Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+7.14%
|
$56,000
$14.4 P/Share
|
|
Apr 15
2025
|
James Richard Porter President and CEO |
SELL
Open market or private sale
|
Direct |
27,000
-2.53%
|
$1,863,000
$69.54 P/Share
|
|
Apr 15
2025
|
James Richard Porter President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
27,000
+8.91%
|
$729,000
$27.85 P/Share
|